Felix Theeuwes

2008

In 2008, Felix Theeuwes earned a total compensation of $1.2M as Chairman and Chief Scientific Officer at DURECT, which was about the same as previous year.

Compensation breakdown

Non-Equity Incentive Plan$25,076
Option Awards$730,608
Salary$464,373
Other$11,987
Total$1,232,044

Theeuwes received $730.6K in option awards, accounting for 59% of the total pay in 2008.

Theeuwes also received $25.1K in non-equity incentive plan, $464.4K in salary and $12K in other compensation.

Rankings

In 2008, Felix Theeuwes' compensation ranked 3,742nd out of 9,135 executives tracked by ExecPay. In other words, Theeuwes earned more than 59.0% of executives.

ClassificationRankingPercentile
All
3,742
out of 9,135
59th
Division
Manufacturing
1,337
out of 3,436
61st
Major group
Chemicals And Allied Products
250
out of 815
69th
Industry group
Drugs
144
out of 597
76th
Industry
Pharmaceutical Preparations
106
out of 408
74th
Source: SEC filing on April 28, 2011.

Theeuwes' colleagues

We found four more compensation records of executives who worked with Felix Theeuwes at DURECT in 2008.

2008

James Brown

DURECT

Chief Executive Officer

2008

Su Yum

DURECT

Executive Vice President, Pharmaceutical Systems R&D

2008

Matthew Hogan

DURECT

Chief Financial Officer

2008

Peter Langecker

DURECT

Chief Medical Officer

News

In-depth

You may also like